Therapeutic efficacy of omalizumab

被引：21

作者：

MacGlashan, Donald, Jr. ^{[1
]}

机构：

[1] Johns Hopkins Asthma & Allergy Ctr, Baltimore, MD 21224 USA

来源：

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY | 2009年 / 123卷 / 01期

关键词：

IgE; basophils; mast cells; asthma; FC-EPSILON-RI; EXPRESSION; BASOPHILS; IGE;

D O I：

10.1016/j.jaci.2008.10.053

中图分类号：

R392 [医学免疫学];

学科分类号：

100102 ;

摘要：

引用

页码：114 / 115

页数：2

共 5 条

[1] Omalizumab-induced reductions in mast cell FcεRI expression and function [J].

Beck, LA ;

Marcotte, GV ;

MacGlashan, D ;

Togias, A ;

Saini, S .

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2004, 114 (03) :527-530

[2] Contribution of dust mite and cat specific IgE to total IgE:: Relevance to asthma prevalence [J].

Erwin, Elizabeth A. ;

Ronmark, Eva ;

Wickens, Kristin ;

Perzanowski, Matthew S. ;

Barry, David ;

Lundback, Bo ;

Crane, Julian ;

Platts-Mills, Thomas A. E. .

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2007, 119 (02) :359-365

[3] RELEASABILITY OF HUMAN BASOPHILS - CELLULAR-SENSITIVITY AND MAXIMAL HISTAMINE-RELEASE ARE INDEPENDENT VARIABLES [J].

MACGLASHAN, DW .

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1993, 91 (02) :605-615

[4]

Saini SS, 2000, J ALLERGY CLIN IMMUN, V106, P514, DOI 10.1067/mai.2000.108431

[5] Asthma symptom re-emergence after omalizumab withdrawal correlates well with increasing IgE and decreasing pharmacokinetic concentrations [J].

Slavin, Raymond G. ;

Ferioli, Catarina ;

Tannenbaum, Stacey J. ;

Martin, Carmen ;

Blogg, Martin ;

Lowe, Philip J. .

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2009, 123 (01) :107-113

← 1 →